Cleveland Clinic on Wednesday announced that it has tapped one of its top biomedical thinkers to direct its innovation program.
WHY IT MATTERS
As the inaugural executive director of Cleveland Clinic Innovations, D. Geoffrey (Geoff) Vince will be tasked with aligning the health system’s technology development plans with emerging research and scientific aims, officials said.
Specifically, this includes “unprecedented growth in data and computing sciences” as researchers in Cleveland and around the world work to discover new drugs, therapeutics and treatment strategies.
Since its founding in 2000, Cleveland Clinic Innovations, the health system’s commercial arm, has helped launch over 80 startup companies whose products were developed through leading-edge medical and technology research and analyzed by clinicians there.
Vince has held the Virginia Lois Kennedy Chair of Biomedical Engineering at Cleveland Clinic for the last decade.
In his new rolehis mandate is to capitalize on important clinical and technological advances to construct strategic alliances and drive revenue growth through the commercialization of intellectual property, officials said.
THE LARGER TREND
Vince’s areas of study include vascular imaging, image and signal processing and atherosclerotic plaque features.
For instance, the group is developing machine learning algorithms based on quantitative ultrasound and acoustic radiation force impulse imaging that can better examine ultrasound images of carotid arteries.
In 2020, Vince was recognized with a Cleveland Clinic award for his notion of a “breathalyzer” for quick COVID-19 diagnosis.
He served as principal investigator on Cleveland Clinic’s National Center for Accelerated Innovations and holds 12 patents and several U.S. Department of Defense grants for his research lab.
A U.K. native, Vince earned his undergraduate degree in medical sciences and chemistry in DeMontford University in Leicester, England, and began his research career at the University of Liverpool, where he earned his PhD in biomedical engineering.
ON THE RECORD
“Dr. Vince’s appointment to the helm of Cleveland Clinic Innovations is a key part of our new global strategy for research and innovations, ” said Cleveland ClinicChief Research and Academic OfficerDr. Serpil Erzurum in a statement.
“His visionary leadership style and wealth of experience in healthcare and industry make him the perfect individual to lead Cleveland Clinic Innovations and its crucial work to advertise the breakthrough inventions of our caregivers into new medical products and businesses that benefit our patients, ” Erzurum added.
“Cleveland Clinic has an extraordinarily innovative culture, in which dentists are invited to develop new ideas to improve patient care, ” said Vince.
“Cleveland Clinic Innovations functions to facilitate those inventions with the most promise for fueling medical advances and economic development in Northeast Ohio. We look forward to continuing this tradition while implementing new business strategies. “